Lipid nutrition and the epidermal barrier: The connection between immune-mediated inflammatory diseases and peroxisome proliferator-activated receptors, a new therapeutic target in psoriasis and atopic dermatitis;Barrera epidérmica y nutrición lipídica. La conexión PPAR e inmunopatología inflamatoria como nuevas dianas de tratamiento en dermatitis atópica y psoriasis

Actas Dermo-Sifiliograficas

Volumn 101, Issue 7, 2010, Pages 585-599

  Villarrubia, V G ^a   Vidal Asensi, S ^b   Perez Banasco V ^c   Cuevas Santos, J ^d   Cisterna Cancer R ^e  

^a Inmunología   (Spain)

^b HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^c Hosp Univ Ciudad de Jaén   (Spain)

^d HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Atopic dermatitis; Epidermal barrier; Interferon ; Interleukin 10; Olive oils; Peroxisome proliferator activated receptors (PPAR); Psoriasis

Indexed keywords

GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN E; INTERLEUKIN 10; LIPID; OLIVE OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ATOPIC DERMATITIS; BACTERICIDAL ACTIVITY; CARDIOVASCULAR DISEASE; DRUG TARGETING; FUNGICIDAL ACTIVITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATORY DISEASE; LIPID METABOLISM; PROTEIN EXPRESSION; PSORIASIS; REVIEW;

EID: 77956823135     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(10)70681-8     Document Type: Review

References (155)

1. Villarrubia VG, Vidal Asensi S, Llácer JM, Llácer A, Iglesias A, Pérez Bañasco V, et al. Barrera epidérmica y nutrición lipídica: personalizando la dermatitis atópica. I. Enzimas reguladoras y proteínas fijadoras de ácidos grasos (FABP) en la conexión PPAR e inmunológica. 2010. [consultado 9-3-2010]. Disponible en: http://www.bioaveda.com/barrera%20epidermica.pdf.
2. M.K. Oyoshi, R. He, L. Kumar, J. Yoon, and R.S. Geha Cellular and molecular mechanisms in atopic dermatitis Adv Immunol 102 2009 135 226
3. M.K. Oyoshi, G.F. Murphy, and R.S. Geha Filaggrin-deficient mice exhibit T(H)17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigens J Allergy Clin Immunol 124 2009 485 493
4. M. Muller, and S. Kersten Nutrigenomics: goals and strategies Nat Rev Genet 4 2003 315 322
5. B. Desvergne, L. Michalik, and W. Wahli Transcriptional regulation of metabolism Physiol Rev 86 2006 465 514
6. P. Germain, B. Staels, C. Dacquet, M. Spedding, and V. Laudet Overview of nomenclature of nuclear receptors Pharmacol Rev 58 2006 685 704
7. H. Sampath, and J.M. Ntambi Polyunsaturated fatty acid regulation of genes of lipid metabolism Annu Rev Nutr 25 2005 317 340
8. B. Desvergne, and W. Wahli Peroxisone proliferator-activated receptors: nuclear control of metabolism Endocr Rev 20 1999 649 688
9. C. Phelps, V. Gburcik, E. Suslova, P. Dudek, F. Forafonov, and N. Bot Fungi and animals may share a common ancestor to nuclear receptors Proc Natl Acad Sci U S A 103 2006 7077 7081
10. M. Bünger, H.M. van den Bosch, J. van der Meijde, S. Kersten, G.J.E.J. Hooiveld, and M. Müller Genome-wide analysis of PPARalpha activation in murine small intestine Physiol Genomics 30 2007 192 204
11. C.T. Phan, and P. Tso Intestinal lipid absorption and transport Front Biosci 6 2001 D299 D319
12. H.M. de Vogel-van des Bosch, M. Bünger, P.J. de Groot, H. Bosch-Vermeulen, G.J.E.J. Hooiveld, and M. Müller PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression BMC Genomics 9 2008 231
13. W.E. Roediger, and S. Nance Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation Br J Exp Pathol 67 1986 773 782
14. H.C. Lee, and Y.H. Wei Mitochondrial role in life and death of the cell J Biomed Sci 7 2000 2 15
15. V. Bocher, I. Pineda-Torra, J.C. Fruchart, and B. Staels PPAR: transcription factors controlling lipid and lipoprotein metabolism Ann N Y Acad Sci 967 2002 7 18
16. P. Sertznig, M. Seifert, W. Tilgen, and J. Reichrath Peroxisome proliferator-activated receptors (PPAR) and the human skin: importance of PPAR in skin physiology and dermatologic diseases Am J Clin Dermatol 9 2008 15 31
17. L. Michalik, and W. Wahli Peroxisome proliferator-activated receptors (PPAR) in skin health, repair and disease Biochim Biophys Acta 1771 2007 991 998
18. E. Fuchs, and V. Horsley More than one way to skin... Genes Dev 22 2008 976 985
19. Y.J. Jiang, Y. Uchida, B. Lu, P. Kim, C. Mao, and M. Akiyama Ceramide stimulates ABCA 12 expression via peroxisome proliferator-activated receptor delta in human keratinocytes J Biol Chem 284 2009 18942 18952
20. G.S.K. Pilgram, D.C.J. Vissers, H. van der Meulen, S. Pavel, S.P.M. Lavrijsen, and J.A. Bouwstra Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis J Invest Dermatol 117 2001 710 717
21. A.V. Rawlings Trends in stratum corneum research and the management of dry skin conditions Int J Cosmet Sci 25 2003 63 95
22. P.G. Sator, J.B. Schmidt, and H. Hönigsmann Comparison of epidermal hydratation and skin surface lipids individuals and in patients with atopic dermatitis J Am Acad Dermatol 48 2003 352 358
23. N.R. Trivedi, Z. Cong, A.M. Nelson, A.J. Albert, L.L. Rosamilia, and S. Sivarajah Peroxisone proliferator-activated receptors increase human sebum production J Invest Dermatol 126 2006 2002 2009
24. D. Staumont-Sallé, G. Abboud, C. Brénuchon, A. Kanda, T. Roumier, and C. Lavogiez Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis J Allergy Clin Immunol 121 2008 962 968
25. R. Behshad, K.D. Cooper, and N.J. Korman A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis Arch Dermatol 144 2008 84 88
26. P. Thuillier, A.R. Brash, J.P. Kehrer, J.B. Stimmel, L.M. Leesnitzer, and P. Yang Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors Biochem J 366 2002 901 910
27. S.J. Muga, P. Thuillier, A. Pavone, J.E. Rundhaug, W.E. Boeglin, and M. Jisaka 8S-lipoxigenase products activate peroxisome proliferator-activated receptor α and induce differentiation in murine keratinocytes Cell Growth Differ 11 2000 447 454
28. M. Westergaard, J. Henningsen, M.L. Svendsen, C. Johansen, U.B. Jensen, and H.D. Schroder Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid J Invest Dermatol 116 2001 702 712
29. M.Y. Sheu, A.J. Fowler, J. Kao, M. Schmuth, K. Schoojans, and J. Auwerx Topical peroxisome proliferator activated receptor-α activators reduce inflammation in irritant and allergic contact dermatitis models J Invest Dermatol 118 2002 94 101
30. K. Mochizuki, H. Mochizuki, H. Kawai, Y. Ogura, M. Shimada, and S. Takase Posible role of fatty acids in milk as the regulador of the expression of cytosolic binding proteins for fatty acids and vitamin A through PPAR in developing rats J Nutr Sci Vitaminol (Tokyo) 53 2007 515 521
31. Villarrubia VG, Moreno Koch MC, Costa LA. El fenotipo inmunoneonatal. III. Impacto de la lactancia materna sobre la salud. An Cient Centro Gallego Buenos Aires 2007; 1:33-48; y en: Villarrubia VG. Impacto de la leche materna sobre la salud. Influencia del aceite de oliva virgen extra. 2006. [consultado 15-8-2009]. Disponible en: http://www.bioaveda.com/foro/lechematerna.pdf.
32. F. Rodríguez de Fonseca, M. Navarro, R. Gómez, L. Escuredo, F. Nava, and J. Fu An anorexia lipid mediator regulated by feeding Nature 414 2001 209 212
33. J. Fu, G. Astarita, S. Gaetani, J. Kim, B.J. Cravatt, and K. Mackie Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine J Biol Chem 282 2007 1518 1528
34. J. Fu, S. Gaetani, F. Oveisi, J. Lo Verme, A. Serrano, and F. Rodríguez de Fonseca Oleoylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha Nature 425 2003 90 93
35. J. Lo Verme, J. Fu, G. Astarita, G. La Rana, R. Russo, and A. Calignano The nuclear receptor peroxisome proliferator-activated receptor-α mediates the anti-inflammatory actions of palmitoylethanolamide Mol Pharmacol 67 2005 15 19
36. V. Pérez-Bañasco, J.M. Gil-Cunquero, F. Borrego-Utiel, M. Gassó, P. Segura-Torres, and F. Warleta Estudio preliminar sobre eficacia y tolerancia de un "coupage" de aceite de oliva en pacientes con enfermedad renal crónica. Evaluación del estado de nutrición Nefrologia 27 2007 472 481
37. V.G. Villarrubia, J.M. Gil-Cunquero, E. Albacete, F. Borrego, and V. Pérez-Bañasco Efectos de un aceite de oliva sobre el colesterol y el estreñimiento en personas de edad avanzada sanos y con enfermedad renal crónica Med Antienvej 11 2007 29 38
38. E. Boelsma, H.F.J. Hendricks, and L. Roza Nutritional skin care: health effects of micronutrients and fatty acids Am J Clin Nutr 73 2001 853 864
39. M.B. Purba, A. Kouris-Blazos, N. Wattanapenpaiboon, W. Lukito, E.M. Rothenberg, and B.C. Steen Skin wrinkling: can food make a difference? J Am Coll Nutr 20 2001 71 80
40. V.G. Villarrubia, A. Llácer Pérez, and J. Bayón Piel y lípidos: dermatitis atópica y aceites de oliva Más Dermatol 7 2009 16 19
41. Vidal-Asensi S, Pérez-Bañasco V, Cisterna-Cáncer R, Villarrubia VG. A blend of extra virgin olive oils ameliorates atopic dermatitis and psoriasis. A pilot study. XVIII Congress EADV, Berlin 2009, 7-11oct; p. 114.
42. M. Schmuth, Y.J. Jiang, S. Dubrac, P.M. Elias, and K.R. Feingold Thematic Review Series: Skin Lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology J Lipid Res 49 2008 499 509
43. B. Hennig, E. Oesterling, and M. Toborek Environmental toxicity, nutrition, and gene interactions in the development of atherosclerosis Nutr Metab Cardiovasc Dis 17 2007 162 169
44. P. Cabras, P. Caboni, M. Cabras, A. Angioni, and M. Russo Rotenone residues on olives and in olive oil J Agric Food Chem 50 2002 2576 2580
45. B. Hennig, G. Reiterer, Z. Majkova, E. Oesterling, P. Meerarani, and M. Toborek Modification of environmental toxicity by nutrients: implications in atherosclerosis Cardiovasc Toxicol 5 2005 153 160
46. N. Benachour, and G.-E. Séralini Glyphosate formulations induce apoptosis and necrosis in human umbilical, embryonic, and placental cells Chem Res Toxicol 22 2009 97 105
47. L. Albanito, R. Lappano, A. Madeo, A. Chimento, E.R. Prossnitz, and A.R. Cappello G-protein-coupled receptor 30 and estrogen receptor-α are envolved in the proliferative effects induced by atrazine in ovarian cancer cells Environ Health Perspect 116 2008 1648 1655
48. P.D. Darbre Environmental oestrogens, cosmetics and breast cancer Best Pract Res Clin Endocrinol Metab 20 2006 121 143
49. E. Diamanti-Kandarakis, J.P. Bourguignon, L.C. Giudice, R. Hauser, G.S. Prings, and A.M. Soto Endocrine-disrupting chemicals: an Endocrine Society scientific statement Endocr Rev 30 2009 293 342
50. R.M. Brand, J. Pike, R.M. Wilson, and A.R. Charron Sunscreens containing physical UV blockers can increase transdermal absorption of pesticides Toxicol Ind Health 19 2003 9 16
51. X. Gu, T. Wang, D.M. Collins, S. Kasichayanula, and F.J. Burczynski In vitro evaluation of concurrent use of commercially available insect repellent and sunscreen preparations Br J Dermatol 152 2005 1263 1267
52. M. Cattani, C. Krzysztof, J. Edwards, and D. Pisaniello Potential dermal and inhalation exposure to chlorpyrifos in Australian pesticide workers Ann Occup Hyg 45 2001 299 308
53. R.M. Brand, and C. Mueller Transdermal penetration of atrazine, alachlor, and trifluralin: effect of formulation Toxicol Sci 68 2002 18 23
54. E.M. Ostrea Jr, E. Villanueva-Uy, D.M. Bielawski, N.C. Posecion Jr, M.L. Corrion, and Y. Jin Maternal hair- an appropriate matriz for detecting maternal exposure to pesticides during pregnancy Environ Res 101 2006 312 322 (Pubitemid 43782664)
55. H.G. Penagos Contact dermatitis caused by pesticides among banana plantation workers in Panama Int J Occup Environ Health 8 2002 14 18
56. H. Penagos, C. Ruepert, T. Partanen, and C. Wesseling Pesticide patch test series for the assessment of allergic contact dermatitis among banana plantation workers in Panama Dermatitis 15 2004 137 145
57. Y. Wohl, I. Goldberg, I. Shirazi, and S. Brenner Chlorpyrifos exacerbating pemphigus vulgaris: a preliminary report and suggested in vitro immunologic evaluation model Skinmed 5 2006 111 113
58. A.R. Pont, A.R. Charron, and R.M. Brand Active ingredients in sunscreens act as topical penetration enhancers for the herbicide 2,4-dichlorophenoxyacetic acid Toxicol Appl Pharmacol 195 2004 348 354
59. M. Mizoi, F. Takabayashi, M. Nakano, Y. An, Y. Sagesaka, and K. Kato The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress Toxicol Lett 158 2005 87 94
60. V.G. Villarrubia, L. Sánchez, and M. Alvárez-Mon Las nuevas vacunas y la respuesta inmunológica. La memoria inmunológica.I. Respuesta humoral frente a respuesta celular Med Clin (Barc) 107 1996 146 154
61. V.G.G. Villarrubia, C. Calvo, and G. Sada Las nuevas vacunas y la respuesta inmunológica. II. El entorno de la presentación antigénica. Adyuvantes como inductores de linfocitos T-inductores de respuestas de mediación celular Med Clin (Barc) 107 1996 185 196
62. A.K. Abbas, K.M. Murphy, and A. Sher Functional diversity of helper T lymphocytes Nature 383 1996 787 793
63. A. O'Garra, and P. Vieira Regulatory T cells and mechanisms of immune system control Nat Med 10 2004 801 805
64. L.E. Harrington, R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, and K.M. Murphy Interleukin-17 producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 2005 1123 1132
65. R.L. Reinhardt, S.J. Kang, H.E. Liang, and R.M. Locksley T helper cell effector fates-who, how and where? Curr Opin Immunol 18 2006 271 277
66. C.T. Weaver, L.E. Harrington, P.R. Mangan, M. Gavrieli, and K.M. Murphy Th17: and effector CD4 T cell lineage with regulatory T cells ties Immunity 24 2006 677 688
67. B. Afzali, G. Lombardi, R.I. Lechler, and G.M. Lord The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease Clin Exp Immunol 148 2007 32 46
68. V. García Villarrubia, and M.C. Moreno Koch Cellular immunity in an experimental ascites tumor: tumor immunostimulation by splenic lymphocytic cells Rev Esp Oncol 28 1981 169 194
69. V.G. Villarrubia, M.C. Moreno Koch, C. G Calvo, S. González, and M. Alvarez-Mon The immunosenescent phenotype in mice and humans can be defined by alterations in the natural immunity. Reversal by immunomodulation with oral AM3 Immunopharmacol Immunotoxicol 19 1997 53 74
70. V.G. Villarrubia, P. González, C. García Calvo, and M. de las Heras Patogenia inmunológica/inflamatoria del asma: El predominio Th2 y su relación con los mecanismos de desvío inmunológico durante las épocas fetal y neonatal. Implicaciones terapéuticas Allergol Immunopathol (Madr) 27 1999 213 231
71. V.G. Villarrubia, and S.R. Navarro Inmunopatogenia del envejecimiento: el deterioro de la inmunidad innata y su repercusión sobre la inmunidad específica. Restauración por AM3 Rev Esp Geriatr Gerontol 35 2000 30 42
72. I.J. O'Shea, and W.E. Paul Regulation of T(H)1 differentiation- controlling the controllers Nat Immunol 3 2002 506 508
73. K.M. Murphy, and S.L. Reiner The lineage decisions of helper T cells Nat Rev Immunol 2 2002 933 944
74. J. Zhu, H. Yamane, J. Cote-Sierra, L. Guo, and W.E. Paul GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors Cell Res 16 2006 3 10
75. D. Agnello, C.S. Lankford, J. Bream, A. Morinobu, M. Gadina, and J.J. O'Shea Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights J Clin Immunol 23 2003 147 161
76. Q. Yu, A. Sharma, S.Y. Oh, H.G. Moon, M.Z. Hossain, and T.M. Salay T cell factor 1 initiates the T helper type fate by inducing the transcription factor GATA-3 and repressing interferon-gamma Nat Immunol 10 2009 992 999
77. E. Betelli, T. Korn, and V.K. Kuchroo Th17: The third member of the effector T cell Trilogy Curr Opin Immunol 19 2007 652 657
78. S. González, M.V. Alcaráz, J. Cuevas, M. Pérez, P. Jaén, and M. Alvarez-Mon An extract of the fern Polypodium leucotomos modulates Th1/Th2 cytokines balance in vitro and appears to exhibit ant-angiogenic activities in vivo: pathogenic relationships and therapeutic implications Anticancer Res 20 2000 1567 1576
79. V.G. Villarrubia, S. González, and J. Cuevas Alteraciones inmunológicas provocadas por la radiación ultravioleta. Su relación patogénica con el fotoenvejecimiento y la aparición de cáncer de piel Piel 11 1996 462 470
80. V.G. Villarrubia, R. Tarazona, R. Solana, and S. González Virus del papiloma humano y radiación ultravioleta: unas amistades peligrosas para la piel (II). Inmunopatogenia del cáncer cutáneo no melanoma. El papel iniciador y promotor de la radiación ultravioleta. Infiltrado inflamatorio y escape tumoral Piel 16 2001 494 505
81. S. Piconese, G. Gri, S. Musio, A. Gorzanelli, B. Frossi, and R. Pedotti Mast cells counteract regulatory T cell suppression through interleukin-6 and OX40/OX40L axis toward Th17 cell differentiation Blood 114 2009 2639 2648
82. L.F. Lu, E.F. Lind, D.C. Gondek, K.A. Bennett, M.V. Gleeson, and K. Pino-Lagos Mast cells are essential intermediaries in regulatory T-cell tolerance Nature 442 2006 997 1002
83. L.H. Glimcher Trawling for treasure: tales of T-bet Nat Immunol 8 2007 448 450
84. J.D. Farrar, W. Ouyang, M. Lohning, M. Assenmacher, A. Raddruch, and O Kanagawa An instructive component in T helper type 2 (Th2) development mediated by GATA-3 J Exp Med 193 2001 643 650
85. I.I. Ivanov, B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, and J.J. Lafaille The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells Cell 126 2006 1121 1133
86. S.F. Ziegler, and J.H. Buckner FOXP3 and the regulation of Treg/Th17 differentiation Microbes Infect 11 2009 594 598
87. D. Mucida, Y. Park, G. Kim, O. Turovskaya, I. Scott, and M. Kronenberg Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid Science 317 2007 256 260
88. S. Xiao, H. Jin, T. Korn, S.M. Liu, M. Oukka, and B. Lim Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signalling and inhibiting IL-6 and IL-23 receptor expression J Immunol 181 2008 2277 2284
89. M. Yamamoto, T. Kamigaki, K. Yamashita, Y. Hori, H. Hasegawa, and D. Kuroda Enhancement of anti-tumor immunity by high levels of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer Oncol Rep 22 2009 337 343
90. F. Annunziato, L. Cosmi, F. Liotta, E. Maggi, and S. Romagnani Human Th17 cells: are they different from murine Th17 cells? Eur J Immunol 39 2009 637 640
91. S.H. Wood, D.N. Clements, W.E. Ollier, T. Nuttal, N.A. McEwan, and S.D. Carter Gene expression in canine atopic dermatitis and correlation with clinical severity scores J Dermatol Sci 55 2009 27 33
92. R. Marsella, and G. Girolomoni Canine models of atopic dermatitis: a useful tool with untapped potential J Invest Dermatol 129 2009 2351 2357
93. K.E. Keppel, K.L. Campbell, F.A. Zuckerman, E.A. Greely, D.J. Schaeffer, and R.J. Husmann Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy Vet Immunol Immunopathol 123 2008 337 344
94. B.A. Osborne, and L.M. Minter Notch signalling during peripheral T-cell activation and differentiation Nat Rev Immunol 7 2007 64 75
95. C.-T. Ong, J.R. Sedy, K.M. Murphy, and R. Kopan Notch and presenilin regulate cellular expansion and cytokine secretion but cannot instruct Th1/Th2 fate acquisition PLoS ONE 3 2008 e2823
96. S.J. Bray Notch signalling: a simple pathway becomes complex Nat Rev Mol Cell Bio 7 2006 678 689
97. S. Demehri, Z. Liu, J. Lee, M.H. Lin, S.D. Crosby, and C.J. Roberts Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity PLoS Biol 6 2008 e123
98. C. Blanpain, W.E. Lowry, H.A. Passoli, and E. Fuchs Canonical nocht signalling functions as a commitment swicht in the epidermal lineage Genes Dev 20 2006 3022 3035
99. A. Al-Shami, R. Spolski, J. Kelly, A. Keane-Myers, and W.J. Leonard A role for TSLP in the development of inflammation in an asthma model J Exp Med 202 2005 829 839
100. Y.J. Liu Thymic stromal lymphopoietin: master swicht for allergic inflammation J Exp Med 203 2006 269 273
101. D.P. Huston, and Y.J. Liu Thymic stromal lymphopoietin: a potential therapeutic target for allergy and asthma Curr Allergy Asthma Rep 6 2006 372 376
102. Y.J. Liu, V. Soumelis, N. Watanabe, T. Ito, Y.H. Wang, and W. Malefyt Rde TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation Annu Rev Immunol 25 2007 193 219
103. Y. Rochman, and W.J. Leonard The role of thymic stromal lymphopoietin in CD8+ T cell homeostasis J Immunol 181 2008 7699 7705
104. I. Rochman, N. Watanabe, K. Arima, Y.J. Liu, and W.J. Leonard Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells J Immunol 178 2007 6720 6724
105. S. Demehri, M. Morimoto, M.J. Holtzman, and R. Kopan Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma PLoS Biol 7 2009 e1000067
106. Z. Zhang, P. Hener, N. Frossard, S. Kato, D. Metzger, and M. Li Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma Proc Natl Acad Sci USA 106 2009 1536 1541
107. E. Guttman-Yassky, M.A. Lowes, J. Fuentes-Duculan, J. Whynot, I. Novitskaya, and I. Cardinale Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis J Allergy Clin Immunol 119 2007 1210 1217
108. D.Y.M. Leung, M. Boguniewicz, M.D. Howell, I. Nomura, and Q.A. Hamid New insights in atopic dermatitis J Clin Invest 113 2004 651 657
109. A.J. van Beelen, M.B. Teunissen, M.L. Kapsenberg, and E.C. de Jong Interleukin-17 in inflammatory skin disorders Curr Opin Allergy Clin Immunol 7 2007 374 381
110. E. Guttman-Yassky, M.A. Lowes, J. Fuentes-Duculan, L.C. Zaba, I. Cardinale, and K.E. Nograles Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis J Immunol 181 2008 7420 7427
111. C. Koga, K. Kabashima, N. Shiraishi, M. Kobayashi, and Y. Tokura Possible pathogenic role of Th17 cells for atopic dermatitis J Invest Dermatol 128 2008 2625 2630
112. J. Louten, K. Boniface, and R. de Waal Malefyt Development and function of Th17 cells in health and disease J Allergy Clin Immunol 123 2009 1004 1011
113. A. Di Cesare, P. Di Meglio, and F.O. Nestle A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J Invest Dermatol 128 2008 2569 2571
114. K.E. Nograles, L.C. Zaba, A. Shemer, J. Fuentes-Duculan, I. Cardinale, and T. Kikuchi IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing T(H)17 T cells J Allergy Clin Immunol 123 2009 1244-5.e2
115. S. Pastore, F. Mascia, and G. Girolomoni The contribution of keratinocytes to the pathogenesis of atopic dermatitis Eur J Dermatol 16 2006 125 131
116. N. Novak, W. Peng, and C. Yu Network of myeloid and plasmocytoid dendritic cells in atopic dermatitis Adv Exp Med Biol 601 2007 97 104
117. L.C. Zaba, J.G. Krueger, and M.A. Lowes Resident and " inflammatory" dendritic cells in human skin J Invest Dermatol 129 2009 302 308
118. L.M. Johnson-Huang, N.S. McNutt, J.G. Krueger, and M.A. Lowes Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases J Clin Immunol 29 2009 247 256
119. V. Dioszeghi, M. Rosas, B.H. Maskrey, C. Colmont, N. Topley, and P. Chaitidis 12/15-Lipoxigenase regulates the inflammatory response to bacterial products in vivo J Immunol 181 2008 6514 6524
120. Y. Cai, R.K. Kumar, J. Zhou, P.S. Foster, and D.C. Webb Ym1/2 promotes Th2 cytokine expression by inhibiting 12/15(S)-lipoxygenase: identification of a novel pathway for regulating allergic inflammation J Immunol 182 2009 5393 5399
121. P.M. Elias, and M. Steinhoff "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis J Invest Dermatol 128 2008 1067 1070
122. P.M. Elias Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis Drug Discov Today Dis Mech 5 2008 e33 e38
123. N. Novak, and T. Bieber Allergic and nonallergic forms of atopic disease J Allergy Clin Immunol 112 2003 252 262
124. V.G. Villarrubia, S. Vidal-Asensi, F. Borrego-Utiel, J.M. Gil-Cunquero, V. Pérez-Bañasco, and R. Cisterna-Cáncer Una formulación estandarizada de aceites de oliva virgen extra orgánicos exhibe potentes efectos antimicrobianos in vitro, Implicaciones en Dermatología Rev Esp Quimioter 2010 (sometido a publicación)
125. E. Elkord Role of regulatory T cells in allergy: implications for therapeutic strategy Inflamm Allergy Drug Targets 5 2006 211 217
126. Y.J. Liu Thymic stromal lymphopoietin and OX40 ligans pathway in the initiation of dendritic cell-mediated allergic inflammation J Allergy Clin Immunol 120 2007 238 244
127. V. Soumelis, P.A. Reche, H. Kanzler, W. Yuan, G. Edward, and B. Homey Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP Nat Immunol 3 2002 673 680
128. S. Esnault, L.A. Rosenthal, D.-S. Wang, and J.S. Malter Thymic stromal lymphopoitein (TSLP) as a bridge between infection and atopy Int J Clin Exp Pathol 1 2008 325 330
129. S. Ebner, V.A. Nguyen, M. Forstner, Y.H. Wang, D. Wolfram, and Y.J. Liu Thymic stromal limphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells J Allergy Clin Immunol 119 2007 982 990
130. Y. Torii, T. Ito, R. Amakawa, H. Sugimoto, H. Amuro, and T. Tanijiri Imidazoquinoline acts as immune adjuvant for functional alteration of thymic stroma lymphopoietin-mediated allergic T cell response J Immunol 181 2008 5340 5349
131. T. Yokoi, R. Amakawa, T. Tanijiri, H. Sugimoto, Y. Torii, and H. Amuro Mycobacterium bovis Bacillus Calmette-Guérin suppresses inflammatory Th2 responses by inducing functional alteration of TSLP-activated dendritic cells Int Immunol 20 2008 1321 1329
132. A. D'Andrea, M. Aste-Amegaza, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells J Exp Med 178 1993 1041 1048
133. G. Abboud, D. Staumont-Sallé, A. Kanda, T. Rounier, N. Deruytter, and C. Lavogiez Fc(epsilon)RI and FcgammaRIII/CD16 differentially regulate atopic dermatitis in mice J Immunol 182 2009 6517 6526
134. C. Bussmann, L. Maintz, J. Hart, J.P. Allam, S. Vrtala, and K.W. Chen Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study Clin Exp Allergy 37 2007 1277 1285
135. C. Schnoeller, S. Rausch, S. Pillai, A. Avagyan, B.M. Wittig, and C. Loddenkemper A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages J Immunol 180 2008 4265 4272
136. K. Nakagome, M. Dohi, K. Okunishi, Y. Komagata, K. Nagatani, and R. Tanaka In vivo IL-10 gene delivery suppresses airway eosinophilia and hyperreactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation J Immunol 174 2005 6955 6966
137. G. Herberth, J. Heinrich, S. Röder, A. Figi, M. Weiss, and U. Diez Reduced IFN-gamma- and enhanced IL-4 producing CD4 cord blood T cells are associated with a higher risk for atopic dermatitis during the first 2 yr of life Pediatr Allergy Immunol 21 1Pt1 2010 5 13
138. E. Machura, B. Mazur, E. Golemiec, M. Pindel, and F. Halkiewicz Staphylococcus aureus skin colonization in atopic dermatitis children is associated with decreased IFN-gamma production by peripheral blood CD4+ and CD8+ T cells Pediatr Allergy Immunol 19 2008 37 45
139. Y.F. Guan, and M.D. Breyer Peroxisome proliferator-activated receptors (PPAR): Novel therapeutic targets in renal disease Kidney Int 60 2001 14 30
140. V.G. Villarrubia, J.M. Gil-Cunquero, and V. Pérez Bañasco Trombosis del acceso vascular en pacientes hemodializados. Racional para el uso del aceite de oliva Nefrologia 27 2007 122 133
141. K. Asadullah, M. Friederich, S. Hanneken, C. Rohrbach, H. Audring, and A. Vergopoulos Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings J Invest Dermatol 116 2001 721 727
142. M. Friederich, W.D. Döcke, A. Klein, S. Phillips, H.D. Volk, and W. Sterry Immunomodulation by imterleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis J Invest Dermatol 118 2002 672 677
143. K. Asadullah, W.D. Döcke, R.V. Sabat, H.D. Volk, and W. Sterry The treatment of psoriasis with IL-10: rationale and review of the first clinical trials Expert Opin Investig Drugs 9 2000 95 102
144. W.D. Döcke, K. Asadullah, G. Belbe, M. Ebeling, C. Höflich, and M. Friederich Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis J Leukoc Biol 85 2009 582 593
145. P.M. Elias An appropriate response to the black-box warning: corrective, barrier repair therapy in atopic dermatitis Clin Med Dermatol 2 2009 1 3
146. M. Kim, M. Jung, S.P. Hong, H. Jeon, M.J. Kim, and M.Y. Cho Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function Exp Dermatol 2009 [PMID: 19703225]
147. L. Suh, S. Coffin, K.H. Leckerman, J.M. Gelfand, P.J. Honig, and A.C. Yan Methicillin-resistant Staphyloccocus aureus colonization in children with atopic dermatitis Pediatr Dermatol 25 2008 528 534
148. Y. Hatano, H. Terashi, S. Arakawa, and K. Katagiri Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by TNF-α and IFN-γ in human epidermis J Invest Dermatol 124 2005 786 792
149. M. Noh, H. Yeo, J. Ko, H.K. Kim, and C.H. Lee MAP17 is associated with the T-helper cell cytokine-induced down-regulation of filaggrin transcription in human keratinocytes Exp Dermatol 19 2010 355 362
150. M.V. Guijarro, J.F. Leal, C. Blanco-Aparicio, S. Alonso, J. Fominaya, and M. Lleonart MAP17 enhances the malignant behavior of tumor cells ROS increase Carcinogenesis 28 2007 2096 2104
151. D.L. Silver, N. Wang, and S. Vogel Identification of small PDZK1-associated protein. DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levels J Biol Chem 278 2003 28528 28532
152. T.M. McKeever, S.A. Lewis, H. Smith, P. Burney, J. Britton, and P.A. Cassano Serum nutrient markers and skin prick testing using data from the Third National Health and Nutrition Examination Survey J Allergy Clin Immunol 114 2004 1398 1402
153. F. Ouyang, R. Kumar, J. Pongracic, R.E. Story, X. Liu, and B. Wang Adiposity, serum lipid levels, and allergic sensitization in Chinese men and women J Allergy Clin Immunol 123 2009 940 948
154. J.M. Gelfand, A.L. Neimann, D.B. Shin, X. Wang, D.J. Margolis, and A.B. Troxel Risk of myocardial infarction in patients with psoriasis JAMA 296 2006 1735 1741 (Pubitemid 44547793)
155. J. Dreiher, D. Weitzman, B. Davidovici, J. Shapiro, and A.D. Cohen Psoriasis and dyslipidemia: a population-based study Acta Derm Venereol 88 2008 561 565